pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics Europe trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 25
- Drugs
- 509
- Patents
- 90
United Therapeutics Europe clinical trials
Registry index of 25 ClinicalTrials.gov studies linked to United Therapeutics Europe programs — each row shows trial ID, program name, phase, status, and indication.
United Therapeutics Europe trial registry — 25 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for United Therapeutics Europe.
-
Autologous Fat Transfer — Phase 2
Clinical update -
DNA vaccine prime — Phase 2
Clinical update -
Group 1: 10 ug FMP012 with 2 ug GLA-SE — Phase 1
Clinical update -
treatment A — Phase 1
Clinical update -
Amodiaquine plus Artesunate co-administration — Approved
Clinical update -
Coartem™ (Artemether-lumefantrine combination) — Approved
Clinical update -
ITDCVC98 — Phase 3
Clinical update -
iron and zinc combined — Approved
Clinical update